These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

342 related items for PubMed ID: 24080895

  • 61. [Schizophrenia and/or bipolar disorder: the neurocognitive endophenotypes].
    Kaladjian A, Azorin JM, Pomietto P, Corréard N, Belzeaux R, Adida M.
    Encephale; 2012 Dec; 38 Suppl 3():S81-4. PubMed ID: 23279993
    [Abstract] [Full Text] [Related]

  • 62.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 63.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 64.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 65. The effect of high vs. low dose lurasidone on eye movement biomarkers of prefrontal abilities in treatment-resistant schizophrenia.
    Karpouzian-Rogers T, Stocks J, Meltzer HY, Reilly JL.
    Schizophr Res; 2020 Jan; 215():314-321. PubMed ID: 31706786
    [Abstract] [Full Text] [Related]

  • 66.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 67. Resting-state brain function in schizophrenia and psychotic bipolar probands and their first-degree relatives.
    Lui S, Yao L, Xiao Y, Keedy SK, Reilly JL, Keefe RS, Tamminga CA, Keshavan MS, Pearlson GD, Gong Q, Sweeney JA.
    Psychol Med; 2015 Jan; 45(1):97-108. PubMed ID: 25066779
    [Abstract] [Full Text] [Related]

  • 68. Neuropsychological performance and spectrum personality traits in the relatives of patients with schizophrenia and affective psychosis.
    Gilvarry CM, Russell A, Hemsley D, Murray RM.
    Psychiatry Res; 2001 Mar 25; 101(2):89-100. PubMed ID: 11286813
    [Abstract] [Full Text] [Related]

  • 69. Antisaccade performance in patients with obsessive-compulsive disorder and unaffected relatives: further evidence for impaired response inhibition as a candidate endophenotype.
    Lennertz L, Rampacher F, Vogeley A, Schulze-Rauschenbach S, Pukrop R, Ruhrmann S, Klosterkötter J, Maier W, Falkai P, Wagner M.
    Eur Arch Psychiatry Clin Neurosci; 2012 Oct 25; 262(7):625-34. PubMed ID: 22437321
    [Abstract] [Full Text] [Related]

  • 70. Biomarker Profiles in Psychosis Risk Groups Within Unaffected Relatives Based on Familiality and Age.
    Türközer HB, Ivleva EI, Palka J, Clementz BA, Shafee R, Pearlson GD, Sweeney JA, Keshavan MS, Gershon ES, Tamminga CA.
    Schizophr Bull; 2021 Jul 08; 47(4):1058-1067. PubMed ID: 33693883
    [Abstract] [Full Text] [Related]

  • 71. Smooth pursuit eye movement deficits as a biomarker for psychotic features in bipolar disorder-Findings from the PARDIP study.
    Brakemeier S, Sprenger A, Meyhöfer I, McDowell JE, Rubin LH, Hill SK, Keshavan MS, Pearlson GD, Tamminga CA, Gershon ES, Keedy SS, Sweeney JA, Clementz BA, Lencer R.
    Bipolar Disord; 2020 Sep 08; 22(6):602-611. PubMed ID: 31721386
    [Abstract] [Full Text] [Related]

  • 72. Dimensions underlying psychotic and manic symptomatology: Extending normal-range personality traits to schizophrenia and bipolar spectra.
    Wilson S, Sponheim SR.
    Compr Psychiatry; 2014 Nov 08; 55(8):1809-19. PubMed ID: 25091283
    [Abstract] [Full Text] [Related]

  • 73. Hippocampal and frontolimbic function as intermediate phenotype for psychosis: evidence from healthy relatives and a common risk variant in CACNA1C.
    Erk S, Meyer-Lindenberg A, Schmierer P, Mohnke S, Grimm O, Garbusow M, Haddad L, Poehland L, Mühleisen TW, Witt SH, Tost H, Kirsch P, Romanczuk-Seiferth N, Schott BH, Cichon S, Nöthen MM, Rietschel M, Heinz A, Walter H.
    Biol Psychiatry; 2014 Sep 15; 76(6):466-75. PubMed ID: 24411473
    [Abstract] [Full Text] [Related]

  • 74. Identification of Distinct Psychosis Biotypes Using Brain-Based Biomarkers.
    Clementz BA, Sweeney JA, Hamm JP, Ivleva EI, Ethridge LE, Pearlson GD, Keshavan MS, Tamminga CA.
    Am J Psychiatry; 2016 Apr 01; 173(4):373-84. PubMed ID: 26651391
    [Abstract] [Full Text] [Related]

  • 75. Failure to mobilize cognitive control for challenging tasks correlates with symptom severity in schizophrenia.
    Baran B, Karahanoğlu FI, Agam Y, Mantonakis L, Manoach DS.
    Neuroimage Clin; 2016 Apr 01; 12():887-893. PubMed ID: 27872811
    [Abstract] [Full Text] [Related]

  • 76. Intrinsic neural activity differences among psychotic illnesses.
    Hudgens-Haney ME, Ethridge LE, Knight JB, McDowell JE, Keedy SK, Pearlson GD, Tamminga CA, Keshavan MS, Sweeney JA, Clementz BA.
    Psychophysiology; 2017 Aug 01; 54(8):1223-1238. PubMed ID: 28419491
    [Abstract] [Full Text] [Related]

  • 77. Robust differences in antisaccade performance exist between COGS schizophrenia cases and controls regardless of recruitment strategies.
    Radant AD, Millard SP, Braff DL, Calkins ME, Dobie DJ, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Lazzeroni LC, Light GA, Meichle SP, Nuechterlein KH, Olincy A, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Swerdlow NR, Sugar CA, Tsuang MT, Turetsky BI, Tsuang DW.
    Schizophr Res; 2015 Apr 01; 163(1-3):47-52. PubMed ID: 25553977
    [Abstract] [Full Text] [Related]

  • 78. Relationship of prolonged acoustic startle latency to diagnosis and biotype in the bipolar-schizophrenia network on intermediate phenotypes (B-SNIP) cohort.
    Massa N, Owens AV, Harmon W, Bhattacharya A, Ivleva EI, Keedy S, Sweeney JA, Pearlson GD, Keshavan MS, Tamminga CA, Clementz BA, Duncan E.
    Schizophr Res; 2020 Feb 01; 216():357-366. PubMed ID: 31796306
    [Abstract] [Full Text] [Related]

  • 79. Local gyrification index in probands with psychotic disorders and their first-degree relatives.
    Nanda P, Tandon N, Mathew IT, Giakoumatos CI, Abhishekh HA, Clementz BA, Pearlson GD, Sweeney J, Tamminga CA, Keshavan MS.
    Biol Psychiatry; 2014 Sep 15; 76(6):447-55. PubMed ID: 24369266
    [Abstract] [Full Text] [Related]

  • 80. Gyrification across psychotic disorders: A bipolar-schizophrenia network of intermediate phenotypes study.
    Rychagov N, Del Re EC, Zeng V, Oykhman E, Lizano P, McDowell J, Yassin W, Clementz BA, Gershon E, Pearlson G, Sweeney JA, Tamminga CA, Keshavan MS.
    Schizophr Res; 2024 Sep 15; 271():169-178. PubMed ID: 39032429
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.